Clinical Trials Logo

Clinical Trial Summary

The goal of this interventional study is to compare the efficacy (surgical field quality and intra-operative blood loss) or cost of TIVA alone to general inhalational anesthetics with intravenous TXA in patient participants who are undergoing endoscopic sinus surgery. The main questions the study aims to answer are: - Is the surgical field quality better when using TIVA alone compared to general inhalational anesthetics with intravenous TXA? - Is one method more financially advantageous to the participant and the institution compared to the other method? Participants will be randomized into one of the two anesthesia cohorts prior to sinus surgery. One group will be given total intravenous anesthesia (TIVA) alone and the other will be given intravenous tranexamic acid (TXA) followed by general inhalational anesthesia. Researchers will compare the TIVA group to the TXA group to see if one group exhibits a better surgery field viewing quality through a subjective evaluation and measurement of blood loss and also which anesthesia regimen is most cost effective upon conducting a cost analysis.


Clinical Trial Description

This study aims to prospectively compare surgical field quality and intraoperative blood loss between patients treated with perioperative intravenous tranexamic acid (TXA) followed by general inhalational anesthesia (sevoflurane, isoflurane, or desflurane) to total intravenous anesthesia (TIVA) alone, which consists of propofol and remifentanil. A secondary objective would be to perform a cost analysis between these two groups to determine whether one method is financially more advantageous than the other. This study will be a prospective double-blinded randomized control trial consisting of patients undergoing endoscopic sinus surgery to assess intraoperative blood loss, surgical field quality, and cost of the medications administered. The control group will receive total intravenous anesthesia without tranexamic acid during surgery. The study group will receive preoperative tranexamic acid with general inhaled anesthetics during surgery (detailed below). Randomization will be conducted via a pre-determined permuted block system (e.g. AABB, ABAB, BBAA, AABB, etc, where A is TIVA and B is general inhalational anesthetics with preoperative TXA). Subjects who consent to participate will be assigned to the A or B arm depending on whichever arm is listed next in the order. Subjects will be informed about the study and consented during pre-operative clinic visits. The patient consent and HIPAA authorization forms will be presented at that time where the subject can read about the study followed by any verbal conversation or questions needed between the subject and the study team. This will be done in a private patient room setting. The subject will be notified that participation in the study is completely voluntary and that their medical care will not be affected regardless of their decision to participate. Of note, if patients decline to participate, they will undergo general anesthesia using TIVA without TXA, as this is the standard choice at our institution. Subjects will not receive payment or compensation for their participation. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05639686
Study type Interventional
Source Our Lady of the Lake Hospital
Contact Christine LeBoeuf, DNP
Phone 225-765-5956
Email christine.leboeuf@fmolhs.org
Status Recruiting
Phase N/A
Start date January 1, 2023
Completion date July 1, 2025

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05923047 - Mepolizumab and In-office Nasal Polypectomy in Patients With Chronic Rhinosinusitis (CRS). A Three Arm Study. Phase 4
Not yet recruiting NCT05836935 - Role of Imaging in Complications of Sinusitis N/A
Not yet recruiting NCT05167552 - Treatment of Allergic Rhinitis and Chronic Polypous Rhinosinusitis With Olfactory Mucosa-derived Mesenchymal Stem Cells Phase 1/Phase 2
Withdrawn NCT04420052 - Effects of Osteopathic Manipulative Treatment in Chronic Non-allergic Rhinosinusitis N/A
Completed NCT04703673 - Sinolpan® Pharmacy Non-interventional Study - Quality of Live
Recruiting NCT05015530 - Impact of Symbiofilm On Nasal Microbiota
Not yet recruiting NCT06105346 - Prevalence of ENT Diseseas
Recruiting NCT05450471 - Effectiveness of Endonasal Polymeric Implant for Chronic Rhinosinusitis Phase 3
Terminated NCT03675022 - Effect of Dupilumab on Sleep Apnea in Patients With Rhinosinusitis Early Phase 1